Basso Capital Management’s NRX Pharmaceuticals NRXP Stock Holding History

Basso Capital Management’s Portfolio NRXP Stock Details NRXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-10,000	Closed	-$1.05M	–	241
2019 Q2	$1.05M	Buy	10,000 +2,140	+27%	+$223K	0.23%	96
2019 Q1	$812K	Buy	7,860 +2,500	+47%	+$257K	0.17%	109
2018 Q4	$547K	Hold	5,360	–	–	0.11%	100
2018 Q3	$537K	Hold	5,360	–	–	0.12%	99
2018 Q2	$531K	Hold	5,360	–	–	0.1%	126
2018 Q1	$526K	Buy	5,360 +360	+7%	+$35.1K	0.1%	125
2017 Q4	$484K	Buy	+5,000	New	+$484K	0.08%	125

Other funds holding NRXP

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

MSU

Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Basso Capital Management's NRXP Position: Q3 2019 in Review

Basso Capital Management sold out of NRX Pharmaceuticals (NRXP) in Q3 2019, closing a stake of 10,000 shares — an estimated $1.05M sold.

Basso Capital Management first reported a position in NRXP in Q4 2017 and held it in 7 quarters. The position peaked at $1.05M in Q2 2019. 15 funds tracked by Wall St. Rank hold NRXP as of Q3 2019.

Basso Capital Management reported no remaining NRX Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Basso Capital Management sold 10,000 NRX Pharmaceuticals shares in Q3 2019, an estimated $1.05M.
Basso Capital Management first reported a position in NRX Pharmaceuticals in Q4 2017 and held it in 7 quarters.
Basso Capital Management's NRX Pharmaceuticals position peaked at $1.05M in Q2 2019.
15 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2019.

Based on Basso Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.